{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:41:40Z","timestamp":1788309700798,"version":"build-2803163510"},"reference-count":30,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Juvenile dermatomyositis (JDM) is the most common form of idiopathic inflammatory myopathy in children. While outcomes are generally thought to be good, persistence of skin rash is a common problem. The goal of this study was to describe the development of clinical treatment plans (CTP) for children with JDM characterized by persistent skin rash despite complete resolution of muscle involvement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>The Childhood Arthritis and Rheumatology Research Alliance, a North American consortium of pediatric rheumatologists and other healthcare providers, used a combination of Delphi surveys and nominal group consensus meetings to develop CTP that reflected consensus on typical treatments for patients with JDM with persistent skin rash.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Consensus was reached on patient characteristics and outcome assessment. Patients should have previously received corticosteroids and methotrexate (MTX). Three consensus treatment plans were developed. Plan A added intravenous immunoglobulin (IVIG) if it was not already being used. Plan B added mycophenolate mofetil, while Plan C added cyclosporine. Continuation of previous treatments, including corticosteroids, MTX, and IVIG, was permitted in plans B and C.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Three consensus CTP were developed for use in children with JDM and persistent skin rash despite complete resolution of muscle disease. These CTP reflect typical treatment approaches and are not to be considered treatment recommendations or standard of care. Using prospective data collection and statistical methods to account for nonrandom treatment assignment, it is expected that these CTP will be used to allow treatment comparisons, and ultimately determine the best treatment for these patients.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.160688","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T01:25:20Z","timestamp":1478049920000},"page":"110-116","source":"Crossref","is-referenced-by-count":65,"title":["Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash"],"prefix":"10.3899","volume":"44","author":[{"given":"Adam M.","family":"Huber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruy","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy D.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homaira","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Byun","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Vehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Juvenile Dermatomyositis Research Committee of the Childhood Arthritis and Rheumatology Research Alliance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"2018112909365491000_44.1.110.1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu289"},{"key":"2018112909365491000_44.1.110.2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22212"},{"key":"2018112909365491000_44.1.110.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(64)80325-5"},{"key":"2018112909365491000_44.1.110.4","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090953"},{"key":"2018112909365491000_44.1.110.5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2004.12.015","article-title":"Cutaneous symptoms of dermatomyositis significantly impact patients\u2019 quality of life","volume":"54","author":"Hundley","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"2018112909365491000_44.1.110.6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11926-014-0467-y","article-title":"The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis","volume":"16","author":"Hoeltzel","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"2018112909365491000_44.1.110.7","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.608376"},{"key":"2018112909365491000_44.1.110.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.23299"},{"key":"2018112909365491000_44.1.110.9","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T"},{"key":"2018112909365491000_44.1.110.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu146"},{"key":"2018112909365491000_44.1.110.11","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1365-2133.2007.07891.x","article-title":"Successful treatment of cutaneous lesions in juvenile dermatomyositis with high-dose intravenous immunoglobulin","volume":"156","author":"Amano","year":"2007","journal-title":"Br J Dermatol"},{"key":"2018112909365491000_44.1.110.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.153718"},{"key":"2018112909365491000_44.1.110.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.068"},{"key":"2018112909365491000_44.1.110.14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-7753(06)72367-3","article-title":"[Efficacy of tacrolimus (FK-506) in the treatment of recalcitrant juvenile dermatomyositis: study of 6 cases]","volume":"127","author":"Mart\u00edn Nalda","year":"2006","journal-title":"Med Clin"},{"key":"2018112909365491000_44.1.110.15","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181da3709"},{"key":"2018112909365491000_44.1.110.16","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3818"},{"key":"2018112909365491000_44.1.110.17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/acr.22259","article-title":"Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis","volume":"66","author":"Ringold","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2018112909365491000_44.1.110.18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","article-title":"Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis","volume":"64","author":"DeWitt","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2018112909365491000_44.1.110.19","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21558"},{"key":"2018112909365491000_44.1.110.20","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2018112909365491000_44.1.110.21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children\u2019s Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res"},{"key":"2018112909365491000_44.1.110.22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2018112909365491000_44.1.110.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1980.tb03924.x"},{"key":"2018112909365491000_44.1.110.24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem179"},{"key":"2018112909365491000_44.1.110.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.23340"},{"key":"2018112909365491000_44.1.110.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.23313"},{"key":"2018112909365491000_44.1.110.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08711.x"},{"key":"2018112909365491000_44.1.110.28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.2007.08342.x","article-title":"Development and validation of the Dermatomyositis Skin Severity Index","volume":"158","author":"Carroll","year":"2008","journal-title":"Br J Dermatol"},{"key":"2018112909365491000_44.1.110.29","doi-asserted-by":"publisher","DOI":"10.1002\/art.10924"},{"key":"2018112909365491000_44.1.110.30","doi-asserted-by":"publisher","DOI":"10.1002\/art.23963"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.160688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T09:01:14Z","timestamp":1718874074000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.160688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,1]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3899\/jrheum.160688"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.160688","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}